A comparison of high cocoa solid with absent cocoa solid chocolate in patients with chronic fatigue syndrome in a double blind randomised controlled trial

ISRCTN ISRCTN03090939
DOI https://doi.org/10.1186/ISRCTN03090939
Secondary identifying numbers ELSY No 2870
Submission date
05/01/2007
Registration date
26/01/2007
Last edited
03/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Stephen Atkin
Scientific

Micheal White Diabetes Centre
Hull Royal Infirmary
Analby Road
Hull
HU3 2RZ
United Kingdom

Study information

Study designDouble blind randomised trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesHigh polyphenol chocolate improves symptoms of Chronic Fatigue Syndrome (CFS)
Ethics approval(s)Hull and East Riding Research Ethics committee on 06/10/2003 (ref: LREC/07/03/121)
Health condition(s) or problem(s) studiedChronic fatigue syndrome
InterventionDouble blind cross over study using chocolate containing high polyphenols with low polyphenol chocolate with two weeks washout, eight weeks of initial intervention and eight weeks of cross-over intervention.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)High polyphenol chocolate
Primary outcome measureImprovement of fatigue using Chandler Fatigue scale, London Handicap Scale and Hospital Anxiety and Depression Scale.
Secondary outcome measuresChange in weight
Overall study start date01/10/2005
Completion date01/10/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants10
Key inclusion criteria1. Age group 18 to 35
2. Diagnosis of CFS as defined by the Centers for Disease Control (CDC) criteria
3. Severity of fatigue - a score of at least ten (out of 11) on the Chalder-Fatigue Scale (binary scored)
Key exclusion criteria1. Benzodiazepine use in the previous two months
2. Unwillilng to give written, informed consent
3. Unable to complete study questionnaires
Date of first enrolment01/10/2005
Date of final enrolment01/10/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Micheal White Diabetes Centre
Hull
HU3 2RZ
United Kingdom

Sponsor information

Hull and East Yorkshire Hospital NHS Trust (UK)
Hospital/treatment centre

c/o Mrs Nina Dunham
Research and Development Department
Castle Hill Hospital
Hull
HU16 5JQ
England
United Kingdom

Website http://www.hey.nhs.uk/
ROR logo "ROR" https://ror.org/01b11x021

Funders

Funder type

Hospital/treatment centre

Research and Development Department, Hull Royal Infirmary (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 22/11/2010 Yes No